A clinical analysis of extrapulmonary complications in novel coronavirus pneumonia patients

Abstract

Objective: This study aimed to investigate the clinical manifestation and treatment effects of extrapulmonary complications in cases of novel coronavirus pneumonia. Methods: The clinical data of patients with novel coronavirus pneumonia who were admitted to Hanchuan People’s Hospital between January and March 2020 were retrospec-tively analyzed, and the clinical characteristics, laboratory test results, and treatment path-ways of patients with extrapulmonary complications were analyzed and summarized. Results: Of the 500 patients in this study, 97 patients with a history of chronic diseases were excluded, and 152 patients had extrapulmonary complications. Common extrapulmonary syndromes: 98 patients (64.47%) suffered from digestive system involvement; 43 patients (28.29%) suffered from cardiovascular system damage; 32 patients (21.05%) had urinary system damage; 25 patients (16.45%) had nervous system damage; and 30 patients (19.74%) had more than two kinds of system damage. In all cases, these patients were treated with comprehensive measures, and effective outcomes were achieved. Conclusion: According to the clinical characteristics and laboratory test results of this sample group, early evaluation of patients with extrapulmonary complications and timely symptomatic treatment can effectively improve outcomes of pneumonia treatment, accelerate the alleviation of symptoms, and improve patients’ condition.